Incoming Montana Gov. Greg Gianforte signaled he won’t continue a statewide mask mandate in place since July, though he said he plans to wear a mask himself and get vaccinated against COVID-19.
If Gianforte, a Republican, reverses outgoing Democratic Gov. Steve Bullock’s mask order, Montana will be just the second state after Mississippi to lift its mandate. Thirty-eight states now have statewide mandates.
“I trust Montanans with their health and the health of their loved ones,” Gianforte said in a recent interview with KHN. “The state has a role in clearly communicating the risks of who is most vulnerable, what the potential consequences are, but then I do trust Montanans to make the right decisions for themselves and their family.”
The Centers for Disease Control and Prevention says masks help prevent transmission of COVID-19. At least one study has found that states with mask requirements have had slower COVID growth rates compared with those without mandates.
“We’re going to encourage people to wear masks,” Gianforte said. “I’m personally going to lead by example, wearing a mask in the Capitol.”
Montana is the only state where control of the governor’s office is changing parties as a result of November’s election. Also, among the 11 governors being sworn in this January, Gianforte will be the only one new to managing his state’s response to the pandemic.
Nine of the others are incumbents starting second terms. The 10th, Spencer Cox, is Utah’s lieutenant governor in the current administration and has played a central role in his state’s COVID response.
Montana alone will have wholly new leadership next year as states try to keep hospitals from overflowing amid the surging virus, while adjusting to a new presidential administration and executing vaccine distribution plans.
Gianforte doesn’t plan to scrap everything the outgoing administration has done to fight the pandemic. For example, he said he and Bullock are “on the same page” when it comes to prioritizing distribution of the vaccine to health care workers and vulnerable residents.
Gianforte also said he plans to take the vaccine when it’s his turn.
“When my name comes up on the list, I will raise my hand and I am going to get vaccinated,” Gianforte said. “It’s very important that I lead by example because I think this vaccine is a critical part of us getting back to normal.”
Gianforte, a businessman who sold his software company, RightNow Technologies, to Oracle for $1.8 billion in 2011, has long coveted Montana’s governor’s office, spending nearly $12 million of his personal fortune over four years and two campaigns to win the seat.
He ran against Bullock and lost in 2016, then won Montana’s congressional seat in a 2017 special election infamous for Gianforte’s misdemeanor assault against a reporter trying to ask him questions.
Gianforte won a second term in Congress in 2018 and defeated Bullock’s lieutenant governor, Mike Cooney, by more than 12 percentage points in November’s election.
Gianforte will be the first Republican in the governor’s office in 16 years. Republican lawmakers, who control the Montana Legislature, cheered Gianforte’s election and have high expectations for the session that begins the day of his inauguration.
Republican lawmakers will likely seek budget cuts after unsuccessfully asking Bullock to preemptively cut state spending during the pandemic. Bullock has said the state is in good financial shape and that any decision to cut spending would be made for ideological reasons, not out of necessity.
Gianforte has declined to indicate whether he plans to support spending cuts, saying his incoming team is still reviewing Bullock’s proposed two-year budget. That budget proposal includes spending increases to Medicaid, support for children and families, senior and long-term care and treatment for addiction and mental disorders.
John Doran, vice president of external affairs for Blue Cross and Blue Shield of Montana, said he hopes lawmakers spare health services used by at-risk residents if they plan to reduce spending to balance the budget.
“These are critical services and the need for them has only increased since the start of the pandemic,” Doran said.
The structure of Montana’s Medicaid expansion program could emerge as one of the more contentious health issues this session. The federal and state health insurance program for people with low incomes or disabilities extended eligibility to Montana adults who make 138% of the federal poverty level in 2015, and it now enrolls more than 90,000 low-income adults.
At least a half-dozen bill requests have been made by Republican lawmakers ahead of the session to revise the Medicaid expansion program, alarming some health care industry officials. Rich Rasmussen, president and CEO of the Montana Hospital Association, said Medicaid expansion has helped small, rural hospitals maintain financial stability, particularly during the COVID crisis.
“We will adamantly oppose any effort to dismantle the program,” Rasmussen said. “We will share with lawmakers how devastating it will be to employers.”
Gianforte said he supports continuing Medicaid expansion but would be willing to revise the program to increase safeguards against fraud. There hasn’t been evidence of widespread fraud in the state’s Medicaid expansion program.
“If we let people sign up for it who are not qualified, the benefits may not be there for the people who really need it,” he said. “So I am open to additional accountability components.”
Gianforte also is expected to be drawn into a legislative debate about changing or limiting the powers of county public health officials. Local conservative leaders and business owners complain that many health officials have overstepped their authority during the pandemic, while at least seven local health leaders have left their positions amid complaints about a lack of support by some county leaders and law enforcement officials in enforcing directives.
Republican Rep. David Bedey is proposing a measure that would require county commissioners to ratify any decisions made by a local public health officer or panel. He said his proposal isn’t meant to take power away from public health officials, but rather to shift the accountability of such decisions to elected officials.
“I do not wish to punish public health officials,” Bedey said. I think they need political cover to do their jobs.”
Bedey’s proposal is one of a handful of bill requests seeking changes in the powers of local health officials. Some health industry officials and lobbyists worry about any infringement on the ability to respond to a public health emergency.
“Local governments are best equipped to make decisions about the health of their communities,” said Amanda Cahill, the Montana government relations director for the American Heart Association and American Stroke Association. “Public health safeguards are more important than ever, and we hope that the ability of local decision-makers to take protective action remains intact.”
KHN's in-depth examination of the year-long pandemic shows that many leading infectious disease specialists underestimated the fast-moving outbreak in its first weeks and months.
This article was published on Monday, December 21, 2020 in Kaiser Health News.
A year ago, while many Americans were finishing their holiday shopping and finalizing travel plans, doctors in Wuhan, China, were battling a mysterious outbreak of pneumonia with no known cause.
Chinese doctors began to fear they were witnessing the return of severe acute respiratory syndrome, or SARS, a coronavirus that emerged in China in late 2002 and spread to 8,000 people worldwide, killing almost 800.
Although the disease hasn't been seen in 16 years, SARS cast a long shadow that colored how many nations — and U.S. scientists — reacted to its far more dangerous cousin, the novel coronavirus that causes COVID-19.
When Chinese officials revealed that their pneumonia outbreak was caused by another new coronavirus, Asian countries hit hard by SARS knew what they had to do, said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security. Taiwan and South Korea had already learned the importance of a rapid response that included widespread testing, contact tracing and isolating infected people.
The U.S., by contrast, learned all the wrong lessons.
KHN's in-depth examination of the year-long pandemic shows that many leading infectious disease specialists underestimated the fast-moving outbreak in its first weeks and months, assuming that the United States would again emerge largely unscathed. American hubris prevented the country from reacting as quickly and effectively as Asian nations, Adalja said.
During the first two decades of this century, "there were a lot of fire alarms with no fire, so people tended to ignore this one," said Lawrence Gostin, director of Georgetown's O'Neill Institute for National and Global Health Law, who acknowledges he underestimated the virus in its first few weeks.
In a Jan. 24 story, Dr. William Schaffner told KHN the real danger to Americans was the common flu, which can kill up to 61,000 Americans a year.
"Coronavirus will be a blip on the horizon in comparison," said Schaffner, a professor of preventive medicine and health policy at Vanderbilt University Medical Center. "The risk is trivial."
The same day, The Washington Post published a column by Dr. Howard Markel, who questioned China's lockdown of millions of people. "It's possible that this coronavirus may not be highly contagious, and it may not be all that deadly," wrote Markel, director of the Center for the History of Medicine at the University of Michigan.
JAMA, one of the most prestigious medical journals in the world, published a podcast Feb. 18 titled, "The 2020 Influenza Epidemic — More Serious Than Coronavirus in the US." A week later, JAMA published a large infographic illustrating the dangers of flu and minimizing the risks from the novel virus.
Dr. Paul Offit, who led development of a rotavirus vaccine, predicted that the coronavirus, like most respiratory bugs, would fade in the summer.
"I can't imagine, frankly, that it would cause even one-tenth of the damage that influenza causes every year in the United States," Offit told Christiane Amanpour in a March 2 appearance on PBS.
Caitlin Rivers, an epidemiologist and assistant professor at the Johns Hopkins Bloomberg School of Public Health, worried — and tweeted — about the novel coronavirus from the beginning. But she said public health officials try to balance those fears with the reality that most small outbreaks in other countries typically don't become global threats.
"If you cry wolf too often, people will never pay attention," said epidemiologist Mark Wilson, an emeritus professor at the University of Michigan School of Public Health.
Experts were hesitant to predict the novel coronavirus was the big pandemic they had long anticipated "for fear of seeming alarmist," said Dr. Céline Gounder, an infectious disease specialist advising President-elect Joe Biden.
Many experts fell victim to wishful thinking or denial, said Dr. Nicole Lurie, who served as assistant secretary for preparedness and response during the Obama administration.
"It's hard to think about the unthinkable," Lurie said. "For people whose focus and fear was bioterrorism, they had a world view that Mother Nature could never be such a bad actor. If it wasn't bioterrorism, then it couldn't be so bad."
Had more experts realized what was coming, the nation could have been far better prepared. The U.S. could have gotten a head start on manufacturing personal protective equipment, ventilators and other supplies, said Dr. Nicholas Christakis, author of "Apollo's Arrow: The Profound and Enduring Impact of Coronavirus on the Way We Live."
"Why did we waste two months that the Chinese essentially bought for us?" Christakis asked. "We could have gotten billions of dollars into testing. We could have had better public messaging that we were about to be invaded. … But we were not prepared."
Dr. Fauci Doesn't Cast Blame
Dr. Anthony Fauci, the nation's top infectious disease official, isn't so critical. In an interview, he said there was no way for scientists to predict how dangerous the coronavirus would become, given the limited information available in January.
"I wouldn't criticize people who said there's a pretty good chance that it's going to turn out to be like SARS or MERS," said Fauci, director of the National Institute of Allergy and Infectious Diseases, noting this was "a reasonable assumption."
It's so easy to go back with the retrospect-o-scope and say 'You coulda, shoulda, woulda.'
— Dr. Anthony Fauci
Fauci noted that solutions are always clearer in hindsight, adding that public health authorities lose credibility if they respond to every new germ as if it's a national disaster. He has repeatedly said scientists need to be humble enough to recognize how little we still don't know about this new threat.
"It's so easy to go back with the retrospect-o-scope and say 'You coulda, shoulda, woulda,'" Fauci said. "You can say we should have shut things down much earlier because of silent spread in the community. But what would the average man or woman on the street have done if we said, 'You've got to close down the country because of three or four cases?'"
Scientists largely have been willing to admit their errors and update their assessments when new data becomes available.
"If you're going to be wrong, be wrong in front of millions of people," Offit joked about his PBS interview. "Make a complete ass of yourself."
Scientists say their response to the novel coronavirus would have been more aggressive if people had realized how easily it spreads, even before infected people develop symptoms — and that many people remain asymptomatic. "For a virus to have pandemic potential, that is one of the greatest assets it can have," Adalja said.
Although COVID-19 has a lower death rate than SARS and MERS, its ability to spread silently throughout a community makes it more dangerous, said Dr. Kathleen Neuzil, director of the Center for Vaccine Development at the University of Maryland School of Medicine.
People infected with SARS and MERS are contagious only after they begin coughing and experiencing other symptoms; patients without symptoms don't spread either disease.
With SARS and MERS, "when people got sick, they got sick pretty badly and went right to the hospital and weren't walking around transmitting it," Christakis said.
Because it's possible to quarantine people with SARS and MERS before they begin spreading the virus, "it was easier to put a moat around them," said Offit.
Based on their knowledge of SARS and MERS, doctors believed they could contain the novel coronavirus by telling sick people to stay home. In the first few months of the pandemic, there appeared to be no need for healthy people to wear masks. That led health officials, including U.S. Surgeon General Jerome Adams, to admonish Americans not to buy up limited supplies of face masks, which were desperately needed by hospitals.
"We are always fighting the last epidemic," Markel said. "Our experiences with coronaviruses was that they kind of burn themselves out in warm weather and they didn't have the capacity to spread as viciously as this one has."
Many scientists were skeptical of early anecdotes of pre-symptomatic spread.
"It takes a lot to overturn established dogma," Wilson said. "Jumping on an initial finding, without corroborating it, can be just as bad as missing a new finding."
I continue to be baffled that we keep making the same mistakes. It's almost like we're doomed to repeat this cycle endlessly.
— Dr. Amesh Adalja
Adalja notes that the CDC's earlier advice against wearing masks was based on research that found them to be ineffective against spreading influenza. New research, however, has shown masks reduce the transmission of the novel coronavirus, which spreads mainly through respiratory droplets but can travel in the air as tiny particles.
Adalja said the U.S. should have learned from its early stumbles. Yet in spite of abundant evidence, many communities still resist mandating masks or physical distancing.
"I continue to be baffled that we keep making the same mistakes," Adalja said. "It's almost like we're doomed to repeat this cycle endlessly."
"We had to immediately react as if this were going to hit every corner of the Earth," said Adalja, who began blogging about the novel virus Jan. 20. It was clear "this was not a containable virus."
Adalja led a 2018 project identifying the features that allow emerging viruses to become pandemic. In that prescient report, Adalja and his co-authors highlighted the threat of certain respiratory viruses that use RNA as their genetic material.
The more Adalja learned about the novel coronavirus, the more it seemed to embody the very type of threat he had warned about: one with "efficient human-to-human transmissibility, an appreciable case fatality rate, the absence of an effective or widely available medical countermeasure, an immunologically naïve population, virulence factors enabling immune system evasion, and respiratory mode of spread."
Adalja and other experts dismissed some of the Trump administration's early responses, such as quarantines and a travel ban on China, as "window dressing" that "squandered resources" and did little to contain the virus.
"There was political inertia about the public health actions that could have avoided lockdowns," Adalja said. "We let this spill into hospitals … [and] if you give a virus a three-month head start, what do you expect?"
Lucey, adjunct professor of infectious diseases at Georgetown University Medical Center, notes that the international response was hampered by misinformation from Chinese officials. "The Chinese government said there was no person-to-person spread," said Lucey, who traveled to China hoping to visit Wuhan. "That was a lie."
When China revealed on Jan. 20 that 14 health workers had been infected, Lucey knew the virus would spread much farther. "To me, that was like Pandora's box," Lucey said. "I knew there would be more."
Although his blog is read by thousands of infectious disease specialists, Lucey emailed a special warning to journalists and a dozen doctors and public health officials, hoping to alert influential leaders.
"I put this heartfelt commentary in my email and just got silence," Lucey said.
Researchers had developed a vaccine against SARS, Fauci said, although the epidemic ended before researchers could widely test it in humans.
"We showed it was safe and induced an immune response," Fauci said. "The cases of SARS disappeared, so we couldn't test it. … We put the vaccine in cold storage. If SARS comes back, we will do a phase 3 [clinical] trial."
Dr. Barney Graham, deputy director of the Vaccine Research Center, asked Chinese scientists to share the coronavirus's genetic information. After the genome was published, Graham went immediately to work.
"We jumped all over it," Fauci said. "We had a meeting on Jan. 10 and five days later they started [working on] a vaccine."
Although scientists knew the COVID outbreak might end before a vaccine was needed, "we couldn't take the chance," Fauci said.
"We said, 'We have no idea what is going to happen, so why don't we just go ahead and proceed with a vaccine anyway?'"
Although his team worried about finding the money to pay for it all, Fauci told them, "'Don't worry about the money. I'll find it, you do it, if we really need it, I'm sure we'll get it.'"
Health experts hope the U.S. will learn from its mistakes and be better prepared for the next threat.
Given how many novel viruses have emerged in the past two decades, it's likely that "pandemics are going to become more frequent," Gounder said, making it critical to be ready for the next one.
Of all the lessons learned during the pandemic, the most important is that "we can't be this unprepared again," said Dr. Tom Frieden, who directed the CDC during the Obama administration.
"To me, this should be the most teachable moment of our lifetime, in terms of the need to strengthen public health in the United States and globally," Frieden said.
But Gounder notes that U.S. public health funding tends to follow a cycle of crisis and neglect. The U.S. increased spending on public health and emergency preparedness after the 9/11 and anthrax attacks in 2001, but that funding has declined sharply over the years.
"We tend to invest a lot in that moment of crisis," Gounder said. "When the crisis fades, we cut the budget. That leads us to be really vulnerable."
In March, during the first week of the San Francisco Bay Area's first-in-the-nation stay-at-home order, KHN spoke with emergency department physicians working on the front lines of the burgeoning COVID-19 pandemic. At the time, these doctors reported dire shortages of personal protective equipment and testing supplies. Health officials had no idea how widespread the virus was, and some experts warned hospitals would be overwhelmed by critically ill patients.
In the end, due to both the early sweeping shutdown order and a state-sponsored effort to bolster the supply chain, Bay Area hospitals were able to avert that catastrophe. The region so far has fared much better than most other U.S. metro regions when it comes to rates of COVID infection and death. Even so, with intensive care unit capacity dwindling to critical levels statewide, San Francisco on Thursday issued another drastic order, announcing a mandatory 10-day quarantine for anyone returning to the city who has spent time outside the region.
Amid this fierce second surge, we circled back last week to check in with Dr. Jeanne Noble, director of the COVID response at the University of California-San Francisco medical center emergency department, to get her reflections on the Bay Area's experience. She explained how even as her hospital has made so many improvements, including recently launching universal testing so that everyone who comes to the emergency room is tested for COVID-19, the lockdown and burnout are wearing on her and her colleagues. The conversation has been edited for length.
Q: How are you doing at UCSF right now?
We're OK in terms of our numbers. We have our ICU capacity; today's numbers are 74% occupied. Acute care is a little bit tighter; the emergency department is seeing an increase in patients. [Editor's note: As of Sunday, ICU capacity had dropped to 13%.]
We did have a period of time before this last surge where we often had a few days with no COVID patients. That was great. That ended in late September. This morning we have 11 patients on ventilators in the ICU.
I think we're the first hospital in the state for universal testing. Everyone who comes to the ER gets tested. I've been working on this for months, but it's new this week. Now we have testing, so we don't have to do so much guesswork.
Q: When we spoke during the week of the first stay-at-home order, back in March, you were very worried. How do things compare now?
The supply [of masks] is just much better than it was back in March. In March, we had furloughed engineers from our local museum, the Exploratorium, making us face shields, and we started a makers lab in the library across the street to make supplies. It doesn't feel like that this time around. We have a longer horizon.
I think in terms of our COVID care and our hospital capacity, we are fine. But my own sort of perspective on all of this is: When are we going to be done with this? Because even though things are smoother — we have PPE, we have testing — it's a tremendous amount of work and stress. Frankly, the fact that my children have not been in school since March is one of my major sources of stress.
We're all working way more than we ever have before. And nine months into it, the adrenaline is gone and it's just purely exhausting.
Q: Can you tell me more about that, the physical and emotional toll on the hospital staff?
We don't allow eating in the ED anymore, so we don't have break rooms. Especially if you're the supervising doctor, you need to do this elaborate handoff to another doctor if you need to eat. You know, it's 10 hours into your shift and you want a cup of coffee.
The hassles and the discomforts. Wearing an N95 day after day is really uncomfortable. A lot of us have ulcers on our noses. They become painful.
And the lack of being able to socialize with colleagues is hard. The ED has always been a pretty intense environment. That's offset by this closeness and being a team. All of this emotional intensity, treating people day after day at these incredible junctures in their lives — a lot of the camaraderie and morale comes from being able to debrief together. When you're not supposed to be closer than a few feet from one another and you don't take off your masks, it's a lot of strain.
People are much less worried about coming home to their families. It hasn't been the fomite disease we were all worried about initially, worried we'd give our kids COVID from our shoes. But there's still the concern. Every time you get a runny nose or a sore throat you need to get tested, and you worry about what if you infected your family.
Q: So will you and your colleagues be able to take a break over the holidays?
We'll see what happens. We're just now starting to feel like we're seeing the post-Thanksgiving numbers. But I think that even without having to do extra shifts in the ED, certainly for someone like me doing COVID response, there's always a huge number of issues to work through. We just got the monoclonal antibodies, which is great, but that's a whole new workflow.
I think what is going to bother people the most is that we are in lockdown. Kind of longing for that relaxation and time with family that we're all kind of craving.
Q: It sounds like things are hard, but the hospital is in a relatively good place.
I was deployed to the Navajo Nation and helped with their surge in May in Gallup, New Mexico, and that is much, much harder than what we've faced in the Bay Area. In Gallup, at Indian Health Service, they were incredible in just the can-do attitude with way fewer resources than we have here. As of this summer, they had had the worst per capita surge in the country. They redesigned their ED essentially by cutting every room in half, hanging plastic on hooks you would use to hang your bicycle wheel. They hung thick plastic and right there doubled their capacity of patients they could see.
Our tents at UCSF are these blue medical tents with HVAC systems, heaters, negative pressure. They are really nice. There they had what looked like beach cabanas — open walls with just a tent overhead. In March and April they were taking care of patients in the snow. In the summer, it was hot and windy. When I was there, almost every single one of my patients had COVID.
That level of intensity was not something we had to go through in the Bay Area. Not to say that it's easy [here]; I just told you all the ways it's hard. But everything is relative. In terms of the COVID landscape, we have been very lucky.
Q: The Bay Area was early to close and has had stricter regulations than many parts of the country. As someone directly affected, what do you think of the response?
I think that we have benefited from early closures, unquestionably, when we did our shelter-in-place in March and probably saved 80,000 lives. It was really a tremendous and a bold move.
We've done some things well and other things not so well. We were very late to implement closures in a targeted fashion. Restaurants and dining reopened this summer, and a lot of us couldn't figure out why indoor dining was open. Why is indoor dining something we need to even be considering when we've just barely flattened our curve? It was very predictable that cases would go up when dining happened. And they did.
We need to evaluate what is more important for our society and well-being, and to say what is the risk associated with that activity. Schools are of high social value. And [the closures are] really hard for kids. We're seeing a lot of adolescents with suicidal ideation brought to the emergency department, which is related to school closure. I would put dining and restaurants as being of minimal social importance and very high risk.
We could have done this better. Closing [down society] when numbers go up is reasonable and that saves lives. But I think we know enough that it should not be an across-the-board closing. I mean, with this latest order, they temporarily closed parks. And we've been telling people to go outside. It's like, what? Are you kidding?
The executive mansion will get a deep clean after two COVID-19 outbreaks this fall led to President Donald Trump and members of his staff and family becoming infected.
This article was published on Monday, December 21, 2020 in Kaiser Health News.
It was a down-in-the-mud presidential campaign, but the dirtiest part comes on Inauguration Day.
As Joe Biden lifts his right hand to take the oath of office at noon on Jan. 20 at the Capitol, a team of specially trained cleaners will be lifting their hands to disinfect the White House.
The executive mansion will get a deep clean after two COVID-19 outbreaks this fall led to President Donald Trump and members of his staff and family becoming infected.
The departure of one president and the arrival of another is always a fast but highly synchronized behind-the-scenes ballet by White House staff members and moving crews.
But this year is different. The shift means more than rearranging the Oval Office and putting new clothes in bedroom closets: It means a top-to-bottom disinfection amid a pandemic. Biden, who at 78 is taking office as the oldest president in U.S. history, is at high risk of complications from the virus.
So, the General Services Administration will oversee a thorough cleaning and disinfection of every doorknob, toilet handle, light switch, stair railing, telephone, elevator button, computer keyboard and other objects inside the 55,000-square-foot mansion at 1600 Pennsylvania Ave.
But can such a large building get fully clean in just five or six hours?
Experts say that should not be a problem with a large enough team and preparation time.
K. Mark Wiencek, lead microbiologist for South Carolina-based Contec Inc., which sells cleaning supplies to hospitals, said GSA cleaners should focus on the rooms last occupied by the Trump staff, since the virus can't survive long on surfaces. Cleaning crews, he added, should wear masks and gloves to protect themselves and not introduce any germs.
He recommended replacing the air filters and using fogging and spraying disinfectant to kill viruses.
The GSA said it is already cleaning the White House East Wing and West Wing offices daily with disinfectant.
GSA officials said they expect no difficulties in making the transition and pledged that all furniture and surfaces would be cleaned. "GSA will thoroughly clean and disinfect the building spaces between the administrations and ensure that everything is up to standard," a spokesperson said in a statement.
It's vital that cleaners leave the cleaning chemicals on surfaces a full 10 minutes before wiping them down, said O.P. Almaraz, a disaster relief expert in West Covina, California, and president of Allied Restoration, which has cleaned dozens of businesses after suspected COVID cases.
"With a large enough crew, a professional disinfection company could apply disinfectants to the entire White House in six hours," he said. It's important, he explained, that the crew pay "special attention to points that may be touched often, like tabletops, door handles and light switches."
As long as cleaners have an organized plan for each room, Almaraz doesn't see them having trouble getting done before the Bidens move in at the end of the day.
Sheldon Yellen, CEO of Michigan-based Belfor Property Restoration, said cleaning crews need to be rehearsed and in fully ventilated suits to clean the White House in one afternoon.
"It's a level 3 clean," he said, noting the building needs the most intensive service because of confirmed COVID cases. That means disposing of anything that doesn't have to stay for the Bidens, including pillows and bedsheets. He said books need to be wiped down, not just on the binding but all sides. He recommended cleaning the ductwork and ventilation systems as well.
Jack Shevel, co-founder of San Diego disinfection company Zappogen, said that because COVID-19 spreads by airborne transmission, it is best to disinfect using an electrostatic sprayer or fogger filled with a disinfectant designed to kill airborne pathogens. That covers a large area more easily than just wiping surfaces.
"To truly disinfect all those rooms quickly and thoroughly, they should be sprayed with a fine micron mist that can reach all crevices and surfaces evenly," he said.
Still, the White House cleaners must be careful to remove paintings, antiques and other valuable items before spraying with disinfectant, said Ernesto Abel-Santos, professor of biochemistry at the University of Nevada-Las Vegas. Those items should be cleaned by hand.
Abel-Santos said a simple alcohol-based disinfectant should be enough to kill the COVID virus. Although the virus can be detected on some surfaces for days, it typically degrades within hours. People are much more likely to be infected by droplets expelled when someone coughs, sneezes or talks.
During the turnover, cleaners should focus on the most commonly used areas of the building, he said, such as the Oval Office and bedrooms. "The rest can get deep-cleaned as needed," he added.
Even more important than cleaning, however, is asking the new president and his family and staff to physically distance, wear their masks and wash their hands, according to Abel-Santos.
"You don't realize how many times in a day you touch your face with your hands," he said. "If you touch a surface and then touch your face, it increases the probability of contagion."
Administrators at Howard University Hospital in Washington, D.C., were thrilled to be among the city's first hospitals to get a COVID-19 vaccine, but they knew it could be a tough sell to get staffers to take the shot.
They were right.
The hospital, located on the campus of one the nation's oldest historically Black colleges, received 725 doses of the vaccine made by Pfizer and BioNTech on Dec. 14 and expects 1,000 more vaccine doses this week to immunize its workers.
Yet, as of Friday afternoon, about 600 employees had signed up for the shots, touted as about 95% effective in preventing the deadly disease. Howard has about 1,900 employees, not counting hundreds of independent contractors it also hoped to vaccinate.
"There is a high level of mistrust and I get it," said Anita Jenkins, the hospital's chief executive officer who received the shot Tuesday in hopes of inspiring her staff to follow her lead. "People are genuinely afraid of the vaccine."
Studies showed few serious side effects in more than 40,000 people before the vaccine was authorized for emergency use in the U.S. A few people worldwide have had allergic reactions in the past week.
In late November, a hospital survey of 350 workers found 70% either did not want to take a COVID vaccine or did not want it as soon as it became available.
So, officials are not dismayed at the turnout so far, saying it shows their educational campaign is beginning to work.
"This is a significant win," said Jenkins, who added she was happy to "take one for the team" when she and other healthcare personnel got the first shots. About 380 Howard employees or affiliated staff had been vaccinated by Friday afternoon.
Although hesitancy toward the vaccine is a challenge nationally, it's a significant problem among Black adults because of their generations-long distrust of the medical community and racial inequities in healthcare.
When Jenkins posted a picture of herself getting vaccinated on her Facebook page, she received many thumbs up but also pointed criticism. "One called me a sellout and asked why I would do that to my people," she said.
Before being vaccinated, Jenkins said, she read about the clinical trials and was glad to learn the first vaccines in development were unlike some that use weakened or inactivated viruses to stimulate the body's immune defense. The COVID vaccine by Pfizer and BioNTech does not contain the actual virus.
And one factor driving her to take the shot was that some employees said they would be more willing to do it if she did.
The hesitancy among her staff members has its roots in the Tuskegee syphilis experiment, said Jenkins, who started at Howard in February.
The 40-year study, which was run by the U.S. Public Health Service until 1972, followed 600 Black men infected with syphilis in rural Alabama over the course of their lives. The researchers refused to tell patients their diagnosis or treat them for the debilitating disease. Many men died of the disease and several wives contracted it.
Jenkins said she was not surprised that many Howard employees — including doctors — are questioning whether to take a vaccine, even though Black patients are twice as likely to die of COVID-19.
While African Americans make up 45% of the population in the District of Columbia, they account for 74% of the 734 COVID deaths. Nationally, Blacks are nearly four times more likely to be hospitalized due to COVID compared with whites and nearly three times more likely to die.
Howard, which has treated hundreds of COVID patients, was one of six hospitals in the city to get the first batch of nearly 7,000 doses of the Pfizer vaccine Monday. About one-third of those doses were administered by Friday morning, said Justin Palmer, a vice president of the District of Columbia Hospital Association.
Federal officials Friday authorized a second vaccine, made by Moderna, for emergency use. That vaccine is expected to be distributed starting this week.
The political bickering over the COVID response has also hurt efforts to instill confidence in the vaccine, Jenkins said.
Other than a sore arm, Jenkins said, she's had no side effects from the vaccine, which can also commonly cause fatigue and headache. "Today I am walking the halls," she explained, "and I got the shot two days ago."
Part of the challenge for Jenkins and other hospital officials will be persuading employees not just to take a vaccine now but to return for the booster shot three weeks later. One dose offers only partial protection.
Jenkins said the hospital plans to make reminder calls to get people to follow up. She said efforts to increase participation at the hospital will also continue.
"It was important for me to be a standard-bearer to show the team I am in there with them," she said.
Like tens of millions of other parents nationwide, Jonathan and Sara Sadowski struggle to assist their four children, ages 5 to 11, with their online schooling at home. In addition, their eldest child, who has cerebral palsy and is in a wheelchair, needs special care.
So to help the kids and keep them safe — especially their oldest child — Jonathan opted to take 12 weeks of paid leave from his teaching job under a program authorized by an emergency federal law enacted in March.
“Qualifying for paid leave was a huge relief and has worked out really well,” said Jonathan, who lives in Concord, New Hampshire.
But the family has learned about a new wrinkle: The 11-year old needs surgery in January. The operation is expected to require a month or two of recovery. Unfortunately, Jonathan’s leave will be used up by then; what’s more, the emergency federal paid leave program it is based on lapses Dec. 31.
Unions and workers’ rights and consumer advocacy groups are this week waging a last-ditch effort to get Congress to extend the program into 2021. They argue that the program is a critical component helping to prevent the spread of the virus and providing financial assistance to struggling families.
They also assert that a number of unwise exemptions — plus a lack of enforcement and public awareness — have limited the program’s effectiveness.
“The emergency paid-leave provisions have been one important step in helping American families deal with this crisis,” said Sen. Kirsten Gillibrand (D-N.Y.). “Congress must extend the provision until this crisis is over. Paid leave is critical as the economy recovers.”
The program is among two dozen pandemic-related relief measures set to expire at the end of the year. Those include unemployment benefits, protections against evictions, student loan relief and payments for COVID testing.
The Democratic-controlled House twice approved bills extending most of those, including paid leave. But Republican leaders in the Senate have until this month refused to consider new relief and stimulus legislation. This week, negotiations have intensified on a compromise bill that extends some of the expiring measures. But an extension of paid sick days and paid leave is not included in that bill.
Capitol Hill staffers and workers’ rights advocates say a paid-leave extension could still be added to the relief bill or a government spending bill that Congress must pass this month.
“It’s outrageous that paid leave is not in this legislation,” said Vicki Shabo, a senior fellow for paid-leave policy and strategy at New America, a Washington think tank. “The evidence is very clear paid sick days and leave help prevent spread of the virus, and it’s a benefit families overwhelmingly want and need.”
Neither the Trump administration nor President-elect Joe Biden responded to requests for comment, and neither has announced a position on the issue.
Paid Sick Leave ‘Is in the Public Interest’
The current law requires businesses with fewer than 500 workers to allow their employees to take up to 10 days of sick leave at full pay and up to 50 more at two-thirds pay to care for a child when schools or day care centers are closed because of COVID-19.
The federal government covers the cost via tax credits to employers. The benefit covers mandatory 14-day quarantine periods for those exposed to the virus, whether they get sick or not.
Larger firms were exempted on the theory that most already provide paid sick days and some forms of extended paid leave — and don’t need federal subsidies.
But an analysis after the law was enacted found that the exemption leaves about 70 million workers in large businesses — roughly half the nation’s workforce — without the full protections offered under the COVID law.
The law and subsequent Department of Labor rules also permit firms with 50 or fewer employees to opt out of providing paid sick days or leave if they think their business will be adversely affected.
About 34 million people work for those small businesses — and the majority offer fewer than 10 paid sick days, if any. Few have extended paid leave.
In addition, the law has no guarantee of paid sick days or leave for the nation’s 13 million health care and emergency response workers.
The justification for that when the measure was enacted: Hospitals, clinics, nursing homes and emergency response companies needed to ensure that these essential workers would show up in a time of crisis.
“This was extremely shortsighted and bad policy,” said Pronita Gupta, director of job quality at the Center for Law and Social Policy in Washington, D.C. “We have seen the harmful outcome — the high number of coronavirus cases in health care facilities, especially among low-wage nursing home workers.”
Nor does the law offer extended paid leave for people who have COVID-19 or need to care for a family member with the disease beyond 10 days. Republicans opposed a broad-based benefit beyond at-home child care, advocates for the benefit noted.
“The problem is we now know that thousands of people who have COVID are sick for more than two weeks, some for months,” said Shabo. “These people need to be able to stay home and recover; that’s in the public interest as well.”
In a letter this month, a coalition of nine national public health groups urged Congress to extend the paid-leave benefits. “Paid sick leave can reduce the spread of COVID-19 in workplaces and communities by removing the barrier to employees staying home if they might have the virus,” the groups wrote. “Even one infection can set off an outbreak.”
Business groups are sympathetic, but some still oppose extending paid leave. Chief among them is the National Federation of Independent Business, a lobbying powerhouse that represents small businesses. Beth Milito, the group’s senior executive counsel, said that while small-business owners have been “highly sensitive” to their workers’ needs during the pandemic, mandating paid sick days and extended leave puts an undue burden on them.
“Figuring out who qualifies, monitoring who takes leave and then applying for the tax credit is all too much red tape,” Milito said. “It’s the hassle factor at a time when many businesses are barely making ends meet.”
Estimates of the Program’s Costs Vary Widely
Surveys show a majority of the estimated 70 million private- and public-sector workers covered under the law — after all the exemptions and carve-outs — don’t know about their right to paid sick days or leave.
“The lack of awareness has limited the potential of this benefit,” said Dawn Huckelbridge, director of the Paid Leave for All campaign, which is supported by a coalition of unions and employees and other groups. The Department of Labor, which administers the benefit, “simply fell down on the job,” she said.
Estimates last spring of the use and cost of the benefit varied widely — from around $20 billion to $105 billion.
But more recent estimates suggest it may be less. According to a Government Accountability Office report citing IRS data, as of the end of October about 150,000 employers had filed for paid family and sick leave tax credits, totaling $1.3 billion. The report noted, however, that many employers will likely wait until filing their taxes in the spring to claim the credit and recoup their costs.
The congressional Joint Committee on Taxation last month released fresh projections on the cost of an extension of paid leave — $1.4 billion if extended for two months and $1.8 billion for three months.
Although it’s too early for any full assessment of the paid-leave program’s impact, advocates point to a key study, published online in October in the journal Health Affairs. Researchers at Cornell University and the KOF Swiss Economic Institute found that in states where workers gained the right to paid sick leave under the emergency law, 400 fewer confirmed COVID cases were reported per day.
The researchers conclude: “Our findings suggest that the U.S. emergency sick leave provision was a highly effective policy tool to flatten the curve in the short run.”
As apprehension about the pandemic intensifies, more Americans — nearly three-quarters — say they wear masks every time they leave the house, according to a poll released Friday.
The poll from KFF also found that 68% of American adults were worried someone in their family will get sick from the coronavirus, the highest level since the nonprofit began tracking the question in February. The public was least worried in April, when 53% were concerned the infection might strike their family. Since April, fewer than half of Republicans have consistently expressed fear that a family member will be sickened by COVID-19. (KHN is an editorially independent program of KFF.)
The latest survey, conducted among 1,676 adults from Nov. 30 to Dec. 8, found that 51% of Americans believed the worst is yet to come from the pandemic, which has claimed more than 300,000 lives in the U.S. The height of optimism occurred in September, when 38% of adults expected things to get worse.
Public support has risen for consistent use of masks, which has been a highly politicized marker of partisan affiliation. The poll found 73% of people said they wear a mask every time they leave home, an increase of 21 percentage points since May due to greater compliance among all partisan and age groups. The same percentage of 73% of respondents said they believe wearing a mask is part of the communal responsibility to prevent the spread of COVID, though nearly half of Republicans view it primarily as a personal choice.
While 87% of Democrats said they always wear a mask out of the house, 71% of independents and 55% of Republicans said the same.
Seven in 10 adults said they are prepared to adhere to physical distancing guidelines for another half-year or more until vaccines are widely available. Nearly 9 in 10 Democrats said they had the wherewithal but only half of Republicans did.
Political leanings polarized people in their views about whether their states have enacted enough restrictions to limit the spread of COVID-19. Half of Republicans thought their state had too many restrictions on businesses, while only 7% of Democrats and 24% of independents did. Four of 10 Republicans thought the state had too many restrictions on individuals, while only 3% of Democrats and 19% of independents did.
About half of Americans said stress related to the coronavirus has affected their mental health. The concerns are most widespread among women, young adults, minorities and people who have lost income, either personally or via their spouse, since the start of the outbreak.
She lay behind a glass barrier, heavily sedated, kept alive by a machine that blew oxygen into her lungs through a tube taped to her mouth and lodged at the back of her throat. She had deteriorated rapidly since arriving a short time earlier.
"Her respiratory system is failing, and her cardiovascular system is failing," said Dr. Luis Huerta, a critical care expert in the intensive care unit. The odds of survival for the patient, who could not be identified for privacy reasons, were poor, Huerta said.
The woman, in her 60s, was among 50 patients so ill with COVID-19 that they required constant medical attention this week in ICUs at Los Angeles County+USC Medical Center, a 600-bed public hospital on L.A.'s Eastside. A large majority of them had diabetes, obesity or hypertension.
An additional 100 COVID patients, less ill at least for the moment, were in other parts of the hospital, and the numbers were growing. In the five days that ended Wednesday, eight COVID patients at the hospital died — double the number from the preceding five days.
As COVID patients have flooded into LAC+USC in recent weeks, they've put an immense strain on its ICU capacity and staff — especially since non-COVID patients, with gunshot wounds, drug overdoses, heart attacks and strokes, also need intensive care.
No more ICU beds were available, said Dr. Brad Spellberg, the hospital's chief medical officer.
Similar scenes — packed wards, overworked medical staffers, harried administrators and grieving families — are playing out in hospitals across the state and the nation.
In California, only 3% of ICU beds were available as of Thursday. In the 11-county Southern California region, no ICU beds were open, and in the San Joaquin Valley, just 0.7% were.
The county of Los Angeles, the nation's largest, was perilously close to zero capacity.
County health officials reported Wednesday that the number of daily new COVID cases, deaths and hospitalizations had all soared beyond their previous highs for the entire pandemic.
LAC+USC has had a heavy COVID burden since the beginning of the pandemic, largely because the low-income, predominantly Latino community it serves has been hit so hard. Latinos represent about 39% of California's population but have accounted for nearly 57% of the state's COVID cases and 48% of its COVID deaths, according to data updated this week.
Many people who live near the hospital have essential jobs and "are not able to work from home. They are going out there and exposing themselves because they have to make a living," Spellberg said. And, he said, "they don't live in giant houses where they can isolate themselves in a room."
The worst cases end up lying amid a tangle of tubes and bags, in ICU rooms designed to prevent air and viral particles from flowing out into the hall. The sickest among them, like the woman described above, need machines to breathe for them. They are fed through nose tubes, their bladders draining into catheter bags, while intravenous lines deliver fluids and medications to relieve pain, keep them sedated and raise their blood pressure to a level necessary for life.
To take some pressure off the ICUs, the hospital this week opened a new "step-down" unit, for patients who are still very sick but can be managed with a slightly lower level of care. Spellberg said he hopes the unit will accommodate up to 10 patients.
Hospital staff members have also been scouring the insurance plans of patients to see if they can be transferred to other hospitals. "But at this point, it's become almost impossible, because they're all filling up," Spellberg said.
Two weeks ago, a smaller percentage of COVID patients in the ER were showing signs of severe disease, which meant fewer needed to be admitted to the hospital or the ICU than during the July surge. That was helping, as Spellberg put it, to keep the water below the top of the levee.
But not anymore.
"Over the last 10 days, it is my distinct impression that the severity has worsened again, and that's why our ICU has filled up quickly," Spellberg said Monday.
The total number of COVID patients in the hospital, and the number in its ICUs, are now well above the peak of July — and both are nearly six times as high as in late October. "This is the worst it's been," Spellberg said. And it will only get worse over the coming weeks, he added, if people travel and gather with their extended families over Christmas and New Year's as they did for Thanksgiving.
"Think New York in April. Think Italy in March," Spellberg said. "That's how bad things could get."
They are already bad enough. Nurses and other medical staffers are exhausted from long months of extremely laborious patient care that is only getting more intense, said Lea Salinas, a nurse manager in one of the hospital's ICU units. To avoid being short-staffed, she's been asking her nurses to work overtime.
Normally, ICU nurses are assigned to two patients each shift. But one really sick COVID patient can take up virtually the entire shift — even with help from other nurses. Jonathan Magdaleno, a registered nurse in the ICU, said he might have to spend 10 hours during a 12-hour shift at the bedside of an extremely ill patient.
Even in the best case, he said, he typically has to enter a patient's room every 30 minutes, because the bags delivering medications and fluids empty at different rates. Every time nurses or other care providers enter a patient's room, they must put on cumbersome protective gear — then take it off when they leave.
One of the most delicate and difficult tasks is a maneuver known as "proning," in which a patient in acute respiratory distress is flipped onto his or her stomach to improve lung function. Salinas said it can take a half-hour and require up to six nurses and a respiratory therapist, because tubes and wires have to be disconnected, then reconnected — not to mention the risks involved in moving an extremely fragile person. And they must do it twice, because every proned patient needs to be flipped back later in the day.
For some nurses, working on the COVID ward at LAC+USC feels very personal. That's the case for Magdaleno, a native Spanish speaker who was born in Mexico City. "I grew up in this community," he said. "Even if you don't want to, you see your parents, you see your grandparents, you see your mom in these patients, because they speak the language."
He planned to spend Christmas only with members of his own household and urged everyone else to do the same. "If you lose any member of your family, then what's the purpose of Christmas?" he asked. "Is it worth it going to the mall right now? Is it worth even getting a gift for somebody who's probably going to die?"
That the darkest hour of the pandemic should come precisely at the moment when COVID vaccines are beginning to arrive is especially poignant, said Dr. Paul Holtom, chief epidemiologist at LAC+USC.
"The tragic irony of this is that the light is at the end of the tunnel," he said. "The vaccine is rolling out as we speak, and people just need to keep themselves alive until they can get the vaccine."
Long-term care residents' participation in the fastest and most extensive vaccination effort in U.S. history is clouded by a significant complication: More than half have cognitive impairment or dementia.
This article was published on Thursday, December 17, 2020 in Kaiser Health News.
Imagine this: Your elderly mother, who has dementia, is in a nursing home and COVID-19 vaccines are due to arrive in a week or two.
You think she should be vaccinated, having heard the vaccine is effective in generating an immune response in older adults. Your brother disagrees. He worries that development of the vaccine was rushed and doesn't want your mother to be among the first people to get it.
These kinds of conflicts are likely to arise as COVID vaccines are rolled out to long-term care facilities across the country.
Navigating Aging focuses on medical issues and advice associated with aging and end-of-life care, helping America's 45 million seniors and their families navigate the healthcare system.
"This is a highly politicized environment, not only with respect to vaccines but also over the existence of the virus itself," said Michael Dark, a staff attorney with California Advocates for Nursing Home Reform. "It's not hard to imagine disputes arising within families."
About 3 million people — most of them elderly — live in nursing homes, assisted living centers and group homes, where more than 105,000 residents have died of COVID-19. They should be among the first Americans to receive vaccines, along with healthcare workers, according to recommendations from the Centers for Disease Control and Prevention and various state plans.
But long-term care residents' participation in the fastest and most extensive vaccination effort in U.S. history is clouded by a significant complication: More than half have cognitive impairment or dementia.
This raises a number of questions. Will all older adults in long-term care understand the details of the vaccines and be able to consent to getting them? If individual consent isn't possible, how will families and surrogate decision-makers get the information they need on a timely basis?
And what if surrogates don't agree with the decision an elderly person has made and try to intervene?
"Imagine that the patient, who has some degree of cognitive impairment, says 'yes' to the vaccine but the surrogate says 'no' and tells the nursing home, 'How dare you try to do this?" said Alta Charo, a professor of law and bioethics at the University of Wisconsin-Madison Law School.
Addressing these issues will occur against a backdrop of urgency. Deaths in long-term care facilities are rising dramatically, with new estimates suggesting that 19 residents die of COVID-19 every hour. With viral outbreaks increasing, already-overwhelmed staffers may not have much time to sit down with residents to answer questions or have conversations with families over the phone.
Meanwhile, CVS and Walgreens, the companies operating vaccine programs at most long-term care facilities, have aggressive timetables. Both companies have said the large-scale rollout of the Pfizer-BioNTech vaccine — the first one that the Food and Drug Administration has authorized — will begin on Dec. 21.But facilities in some states may get supplies earlier. Altogether, there are more than 15,000 nursing homes and nearly 29,000 assisted living residences in the U.S.
At a meeting of the federal Advisory Committee on Immunization Practices early this month, Dr. Nancy Messonnier, director of the CDC's National Center for Immunization and Respiratory Diseases, acknowledged the agency was "very concerned" that information about vaccines be adequately explained to long-term care residents. "It's very important for the frail elderly not only to ensure that they are understanding the vaccine that they're getting but also that their family members do," she said.
Each vaccine manufacturer will be required to prepare a fact sheet describing what's known about benefits and risks associated with a vaccine, what's not known, and making it clear that a vaccine has received "emergency use authorization" from the FDA — a conditional endorsement that falls short of full approval. A second vaccine, from Moderna, is poised to receive this kind of authorization after an FDA meeting on Thursday.
Something that will need to be made clear to residents: while vaccines have been tested on people age 65 and older, those tests did not include individuals living in long-term care, according to Dr. Sara Oliver, a CDC expert.
Some operators have crafted communication plans around the vaccines and already begun intensive outreach. Others may not be well prepared.
Juniper Communities operates 22 senior housing communities (a standalone nursing home, multiple memory care and assisted living facilities, and two continuing care retirement communities) in Colorado, New Jersey and Pennsylvania. This week, it is planning an hour-long town hall videoconferencing session for residents and families about coronavirus vaccines. Last week, it held a similar event for staffers.
Juniper has contracted with CVS, which is requiring that every resident and staff member fill out consent forms in triplicate before being inoculated. When written consent can't be obtained directly, verbal consent, confirmed independently, may substitute. Walgreens has similar requirements.
For residents with memory impairment, two Juniper nurses will reach out by phone to whomever has decision-making authority. "One will ask questions and obtain verbal consent; the other will serve as a witness," said Lynne Katzmann, Juniper's founder and chief executive officer. Separately, emails, blog posts and prerecorded voice messages about the vaccines have gone out to Juniper residents and staffers, starting at the end of November.
A key message is "we've done this before, not at this scale, mind you, and not at this level of import, but we do flu vaccinations annually," said Katzmann, who plans to be the first Juniper employee to get the Pfizer vaccine when it comes to New Jersey.
At Genesis Healthcare, crucial messages are "these vaccines have been studied thoroughly, tens of thousands of people have received them already, they're very, very effective, and no steps have been skipped in the scientific process," said Dr. Richard Feifer, executive vice president and chief medical officer. Genesis, the nation's largest long-term care company, operates more than 380 nursing homes and assisted living residences in 26 states, with about 45,000 employees and more than 30,000 residents.
Medical directors at each Genesis facility have been scheduling video conferences with families, residents and staffers during the past few weeks to address concerns. They've also distributed a letter and a question-and-answer document prepared by the Society for Post-Acute and Long-Term Care Medicine, in addition to getting information out through closed-circuit TV channels and social media.
In partnership with Brown University researchers, the company will monitor daily the side effects that its long-term care residents experience after getting coronavirus vaccines. Most reactions are expected to be mild or moderate and resolve within a few days. They include fatigue, pain at the injection site, headaches, body aches, fever and, rarely, allergic responses.
Administering the vaccine will occur over three visits for all long-term care facilities. At the first, all Genesis residents and staffers will get inoculations. At the second, three to four weeks later, those same people will get a second dose, and new staffers and residents will get a first dose. At the third, those who still qualify for a second vaccine dose will get one.
What will happen if lots of people experience uncomfortable side effects and employees don't come in for a couple of days while recovering? "It's a very difficult problem and we're making contingency plans to address it," Feifer said.
And what about continuing care retirement communities — also known as "life plan communities" — where residents in skilled nursing, assisted living and independent living can reside in close proximity?
That's the case at Bayview in Seattle, which houses 210 residents in a 10-story building. For the moment, independent living residents aren't on the priority list but "I know there will be a contingent of residents and staff who won't want to be vaccinated and we'll see if we can use those vaccines for our independent living people instead," said Joel Smith, Bayview's health services administrator.
Logistical challenges are sure to arise, but many operators have an acute sense of mission. "It is critical that we lead the way out of this crisis," Feifer of Genesis said. "Nursing homes need to go first and be the first ones to address vaccine hesitancy head-on and be successful at generating a high level of acceptance. There is no alternative, no Plan B right now. We have to be successful."
When her husband was diagnosed with early-stage Alzheimer's disease in 2015, Elizabeth Pan was devastated by the lack of options to slow his inevitable decline. But she was encouraged when she discovered the work of a UCLA neurologist, Dr. Dale Bredesen, who offered a comprehensive lifestyle management program to halt or even reverse cognitive decline in patients like her husband.
After decades of research, Bredesen had concluded that more than 36 drivers of Alzheimer's cumulatively contribute to the loss of mental acuity. They range from chronic conditions like heart disease and diabetes to vitamin and hormonal deficiencies, undiagnosed infections and even long-term exposures to toxic substances. Bredesen's impressive academic credentials lent legitimacy to his approach.
Pan paid $4,000 to a doctor trained in Bredesen's program for a consultation and a series of extensive laboratory tests, then was referred to another doctor, who devised a stringent regimen of dietary changes that entailed cutting out all sugars, eating a high-fat, low-carbohydrate diet and adhering to a complex regimen of meditation, vigorous daily exercise and about a dozen nutritional supplements each day (at about $200 a month). Pan said she had extensive mold remediation done in her home after the Bredesen doctors told her the substance could be hurting her husband's brain.
But two years passed, she said, and her husband, Wayne, was steadily declining. To make matters worse, he had lost more than 60 pounds because he didn't like the food on the diet. In April, he died.
"I imagine it works in some people and doesn't work in others," said Pan, who lives in Oakton, Virginia. "But there's no way to tell ahead of time if it will work for you."
Bredesen wrote the best-selling 2017 book "The End of Alzheimer's" and has promoted his ideas in talks to community groups around the country and in radio and TV appearances like "The Dr. Oz Show." He has also started his own company, Apollo Health, to market his program and train and provide referrals for practitioners.
Unlike other self-help regimens, Bredesen said, his program is an intensely personalized and scientific approach to counteract each individual's specific deficits by "optimizing the physical body and understanding the molecular drivers of the disease," he told KHN in a November phone interview. "The vast majority of people improve" as long as they adhere to the regimen.
Bredesen's peers acknowledge him as an expert on aging. A former postdoctoral fellow under Nobel laureate Stanley Prusiner at the University of California-San Francisco, Bredesen presided over a well-funded lab at UCLA for more than five years. He has been on the UCLA faculty since 1989 and also founded the Buck Institute for Research on Aging in Marin County. He has written or co-authored more than 200 papers.
But colleagues are critical of what they see as his commercial promotion of a largely unproven and costly regimen. They say he strays from long-established scientific norms by relying on anecdotal reports from patients, rather than providing evidence with rigorous research.
"He's an exceptional scientist," said George Perry, a neuroscientist at the University of Texas-San Antonio. "But monetizing this is a turnoff."
"I have seen desperate patients and family members clean out their bank accounts and believe this will help them with every ounce of their being," said Dr. Joanna Hellmuth, a neurologist in the Memory and Aging Center at UCSF. "They are clinging to hope."
Many of the lifestyle changes Bredesen promotes are known to be helpful. "The protocol itself is based on very low-quality data, and I worry that vulnerable patients and family members may not understand that," said Hellmuth. "He trained here" — at UCSF — "so he knows better."
The Bredesen package doesn't come cheap. He has built a network of practitioner-followers by training them in his protocol — at $1,800 a pop — in seminars sponsored by the Institute for Functional Medicine, which emphasizes alternative approaches to managing disease. Apollo Health also offers two-week training sessions for a $1,500 fee.
Once trained in his ReCODE Protocol, medical professionals charge patients upward of $300 for a consultation and as much as $10,500 for eight- to 15-month treatment packages. For the ReCODE protocol, aimed at people already suffering from early-stage Alzheimer's disease or mild cognitive decline, Apollo Health charges an initial $1,399 fee for a referral to a local practitioner that includes an assessment and extensive laboratory tests. Apollo then offers $75-per-month subscriptions that provide cognitive games and online support, and links to another company that offers dietary supplements for an additional $150 to $450 a month. Insurance generally covers little of these costs.
Apollo Health, founded in 1998 and headquartered in Burlingame, California, also offers a protocol geared toward those who have a family history of dementia or want to prevent cognitive decline.
Bredesen estimates that about 5,000 people have done the ReCODE program. The fees are a bargain, Bredesen said, if they slow decline enough to prevent someone from being placed in a nursing home, where yearly costs can climb past $100,000 annually.
Bredesen and his company are tapping into the desperation that has grown out of the failure of a decades-long scientific quest for effective Alzheimer's treatments. Much of the research money in the field has narrowly focused on amyloid — the barnacle-like gunk that collects outside nerve cells and interferes with the brain's signaling system — as the main culprits behind cognitive decline. Drugmakers have tried repeatedly, and thus far without much success, to invent a trillion-dollar anti-amyloid drug. There's been less emphasis in the field on the lifestyle choices that Bredesen stresses.
"Amyloids sucked up all the air in the room," said Dr. Lon Schneider, an Alzheimer's researcher and a professor of psychiatry and behavioral sciences at the Keck School of Medicine at USC.
Growing evidence shows lifestyle changes help delay the progress of the mind-robbing disease. An exhaustive Lancet report in August identified a long list of risk factors for dementia, including excessive drinking, exposure to air pollution, obesity, loss of hearing, smoking, depression, lack of exercise and social isolation. Controlling these factors — which can be done on the cheap — could delay or even prevent up to 40% of dementia cases, according to the report.
Bredesen's program involves all these practices, with personalized bells and whistles like intermittent fasting, meditation and supplements. Bredesen's scientific peers question whether data supports his micromanaged approach over plain-vanilla healthy living.
Bredesen has publishedthree papersshowing positive results in many patients following his approach, but critics say he has fallen short of proving his method's effectiveness.
The papers lack details on which protocol elements were followed, or the treatment duration, UCSF's Hellmuth said. Nor do they explain how cognitive tests were conducted or evaluated, so it's difficult to gauge whether improvements were due to the intervention, to chance variations in performance or an assortment of other variables, she said.
Bredesen shrugs off the criticism: "We want things to be in an open-access journal so everybody can read it. These are still peer-reviewed journals. So what's the problem?"
Another problem raised about Bredesen's enterprise is the lack of quality control, which he acknowledges. Apollo-trained "certified practitioners" can include everyone from nurses and dietitians to chiropractors and health coaches. Practitioners with varying degrees of training and competence can take his classes and hang out a shingle. That's a painful fact for some who buy the package.
"I had the impression these practitioners were certified, but I realize they all had just taken a two-week course," said a Virginia man who requested anonymity to protect his wife's privacy. He said that he had spent more than $15,000 on tests and treatments for his ailing spouse and that six months into the program, earlier this year, she had failed to improve.
Bredesen said he and his staff were reviewing "who's getting the best results and who's getting the worst results," and intended to cut poor performers out of the network. "We'll make it so that you can only see the people getting the best results," he said.
Colleagues say that to test whether Bredesen's method works it needs to be subjected to a placebo-controlled study, the gold standard of medical research, in which half the participants get the treatment while the other half don't.
In the absence of rigorous studies, said USC's Schneider, a co-author of the Lancet report, "saying you can 'end Alzheimer's now and this is how you do it' is overpromising and oversimplifying. And a lot of it is just common sense."
Bredesen no longer says his method can end Alzheimer's, despite the title of his book. Apollo Health's website still makes that claim, however.